NRAS |
NRAS, HRAS1: GTPase NRas precursor |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
38.160 |
Evidence |
|
CCNB1 |
Cyclin B1 |
AKAP8L |
AKAP8L, NAKAP95, HRIHFB2018: A-kinase anchor protein 8-like |
38.160 |
Evidence |
|
AKT1 |
AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
38.160 |
Evidence |
|
BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
38.160 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PTPN12 |
PTPN12: Tyrosine-protein phosphatase non-receptor type 12 |
38.160 |
Evidence |
O
|
IQGAP1 |
IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
38.160 |
Evidence |
|
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
CRKL |
CRKL: Crk-like protein |
38.160 |
Evidence |
|
NRAS |
NRAS, HRAS1: GTPase NRas precursor |
STK3 |
STK3, MST2: Serine/threonine-protein kinase 3 |
38.160 |
Evidence |
|
MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
38.160 |
Evidence |
|
BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
38.160 |
Evidence |
O
|
EIF5B |
EIF5B, IF2, KIAA0741: Eukaryotic translation initiation factor 5B |
ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
38.160 |
Evidence |
|
CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
38.160 |
Evidence |
|
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
PRKCQ |
PRKCQ, PRKCT: Protein kinase C theta type |
38.160 |
Evidence |
|
NRAS |
NRAS, HRAS1: GTPase NRas precursor |
PKN2 |
PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 |
38.160 |
Evidence |
|
XPO1 |
XPO1, CRM1: Exportin-1 |
RANBP2 |
RANBP2, NUP358: E3 SUMO-protein ligase RanBP2 |
38.160 |
Evidence |
O
|
COPB2 |
COPB2: Coatomer subunit beta' |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
38.160 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
CRKL |
CRKL: Crk-like protein |
38.160 |
Evidence |
|
RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
38.160 |
Evidence |
|
ACTR3 |
ACTR3, ARP3: Actin-related protein 3 |
CFL1 |
CFL1, CFL: Cofilin-1 |
38.160 |
Evidence |
|
ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
38.160 |
Evidence |
|
FGA |
IPI00021885 |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
38.160 |
Evidence |
|
HDAC3 |
HDAC3: Histone deacetylase 3 |
MBD3 |
MBD3: Methyl-CpG-binding domain protein 3 |
38.160 |
Evidence |
|
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
38.160 |
Evidence |
|
RPLP0 |
RPLP0: 60S acidic ribosomal protein P0 |
RPL8 |
RPL8: 60S ribosomal protein L8 |
38.090 |
Evidence |
|
LCP1 |
LCP1, PLS2: Plastin-2 |
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
38.080 |
Evidence |
|